B. Nguyen, None; G. Vizzeri, None; P.A. Sample, Carl Zeiss Meditec, Inc., F; Haag-Streit, F; Welch-Allyn, F; R.N. Weinreb, Carl Zeiss Meditec, Inc., F; Heidelberg Engineering, GmbH, F; Novartis, F; Optovue, Inc., F; Topcon Medical Systems, Inc., F; Alcon Laboratories, Inc., C; Allergan, Inc., C; Carl Zeiss Meditec, Inc., C; Glaxo, C; Optovue, Inc., C; Pfizer, Inc., C; Topcon Medical Systems, Inc., C; P. Sassani, None; F.A. Medeiros, Carl Zeiss Meditec, Inc., F; Pfizer, Inc., F; Alcon Laboratories, Inc., C; Alcon Laboratories, Inc., F; Allergan, Inc., C; Pfizer, Inc., C; Alcon Laboratories, Inc., R; Allergan, Inc., R; Carl Zeiss Meditec, Inc., R; Pfizer, Inc., R; Reicherts, Inc., R; C.A. Girkin, Alcon Laboratories, Inc., C; Allergan, Inc., C; Pfizer, Inc., C; Heidelberg Engineering, GmbH, R; Optive, Inc., R; Carl Zeiss Meditec, Inc., R; Merck, Inc., R; J.M. Liebmann, Carl Zeiss Meditec, Inc., F; Diopsys, Inc., F; Optovue, Inc., F; Topcon Medical Systems, Inc., F; Alcon Laboratories, Inc., C; Allergan, Inc., C; Diopsys, Inc., C; Optovue, Inc., C; Pfizer, Inc., C; Topcon Medical Systems, Inc., C; L.M. Zangwill, Carl Zeiss Meditec, Inc., F; Heidelberg Engineering, GmbH, F; Optovue, Inc., F; Topcon Medical Systems, Inc., F.